Molecular Therapeutics Initiative

Thank you to Michael Ward for presenting his amazing science today addressing urgent problems in neurodegenerative disease at a joint #MolecularTherapeutics, @MTI_UCB, and Neuroscience talk at @UCBerkeley today! Great science helping patients is more important than ever!

🌍What if we could paralyze parasites - without harming human cells? 2025 MTI Innovator Dr. Matt Welch is targeting kinesin motor proteins in Trypanosoma brucei to develop new therapies for African sleeping sickness and other neglected diseases. New hope for the world’s most…

Grateful to everyone who brought #BayAreaBiotechDay to life yesterday at @UCBerkeley! It was incredible to see the energy in the room and the cutting-edge advances shared by leaders in both academia and industry. Excited to see what’s next for biotech!

🚨 Bay Area Biotech Day hits @UCBerkeley next week (7/22)! Hear Nobel laureate Carolyn Bertozzi + leaders from Denali, Calico, Frontier, Nurix, Arcus & more on the next wave of drug discovery. 🧬 Posters, panels & networking. #Biotech #DrugDiscovery #UCBerkeley

🚀 MTI member & board advisor Jennifer Doudna & Priscilla Chan launch @UCSF Center for Pediatric #CRISPR Cures with $20M from @ChanZuckerberg. First 8 kids set for custom gene edits - built on #BabyKJ success. Read: time.com/7300257/center… #GeneTherapy #RareDisease

Big news: We’re proud to support the launch of the Center for Pediatric CRISPR Cures at @UCSF and @UCBerkeley which will bring personalized CRISPR cures to children with rare genetic diseases. 🔗 chanzuckerberg.com/newsroom/cente…

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth. But there's a new source of hope for many of these families: the Center for Pediatric CRISPR Cures at the University of…

🚀 Bay Area Biotech Day lands @UCBerkeley 7/22! Hear Nobel Laureate Carolyn Bertozzi + leaders from Denali Therapeutics, Calico Labs, Frontier Medicines & more leaders in biotechnology unveil the next wave in drug discovery. Scan the QR on the flyer to register now! 🧬🥂

Big congrats to MTI and MTx faculty member Markita Landry (@UCBerkeley) on winning a Guggenheim Fellowship! Her new project explores plant-based compounds from Indigenous Bolivian medicine as potential neurotherapeutics. 🌿🧠 🔗 news.berkeley.edu/2025/04/22/two… #MTI #Neurotech…

Excited to announce a new collaboration between the Molecular Therapeutics Initiative (MTI) and Amgen Inc.! This partnership includes funding for cutting-edge research & an internship program for grad students to train in drug discovery & development at Amgen. #MTI #Amgen…

🧬 Big things are happening at UC Berkeley! Come to “Hardly Strictly Synapses” - a one-day symposium celebrating the new Neuroscience Department 🎉 📅 June 3 | 9 - 4:30 | Li Ka Shing 🎤 Nobel Laureate Thomas Südhof, Eric Gouaux + top neuro speakers 💡 Student talks, molecular…

🚨 Big win for Berkeley in the CRISPR patent battle: A federal appeals court says the USPTO got it wrong - Broad’s patent claims were legally flawed. The case now heads back for reconsideration. Dr. Jennifer Doudna, original co-inventor and MTI board member is still leading the…

🧪 Can we teach cancer cells to take out their own trash? 2025 MTI Innovators Rumi Sherriff (PhD candidate) & Dr. James Olzmann are designing molecular glues to induce degradation of mutant lipid kinases - drivers in deadly blood cancers. #MTIAwards #CancerResearch…

Congratulations to #MolecularTherapeutics faculty and @MTI_UCB member @OlzmannLab for receiving the Beatriz Manz award for 'transformational teaching and community service'. Glad to have you as a friend and colleague @UCBerkeley , James!